Targeted Therapy Holds Future Promise
July 9, 2017
In many areas of medicine, treatments are increasingly becoming targeted in a way that benefits patients. This is happening in fields ranging from oncology to neurological disease. In this month’s Neurology Now, treatment for autoimmune encephalitis is being cited as one area where “precision medicine” holds promise for better and targeted treatments according to antibody status in the near future. Researchers in labs across the globe are discovering how the various antibodies in AE affect specific parts of the brain and produce overlapping but distinct syndromes. Novel antibodies that affect brain function are being discovered every few months and also suggest the possibility exists for targeted therapies as the field of neuroimmunology grows and evolves. To read the full article on precision medicine where AE is mentioned under “Developments in Precision Medicine,” please click here.
Post by
Lynn Chapman
